| Views | |
|---|---|
| Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment | 114 |
| September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | |
|---|---|---|---|---|---|---|---|
| Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment | 4 | 9 | 4 | 1 | 6 | 5 | 4 |
| Views | |
|---|---|
| Elagin_Correction.pdf | 46 |
| Views | |
|---|---|
| United States | 36 |
| Canada | 12 |
| Germany | 5 |
| Vietnam | 5 |
| Russia | 4 |
| Brazil | 2 |
| Czech Republic | 2 |
| Ecuador | 2 |
| Netherlands | 2 |
| Australia | 1 |
| Views | |
|---|---|
| Ottawa | 12 |
| Palo Alto | 4 |
| San Jose | 4 |
| Hanoi | 3 |
| Fairfield | 2 |
| Quito | 2 |
| San Francisco | 2 |
| Wilmington | 2 |
| Amsterdam | 1 |
| Asheville | 1 |